Nasdaq Stockholm AB has assessed that Flerie AB, company registration number 559067-6820, fulfills Nasdaq Stockholm's listing requirements. Provided that the prospectus is approved by the SFSA first day of trading is expected to June 27, 2024. The shares are currently traded on Nasdaq First North Growth Market. As per today's date the company has a total of 7,806,640,598 shares. Short Name: Flerie -------------------------------------------------------- ISIN Code: SE0008966295 -------------------------------------------------------- Order book id: 127479 -------------------------------------------------------- Number of shares to be listed: 7,806,640,598 -------------------------------------------------------- Clearing: CCP Cleared -------------------------------------------------------- Segment: Mid Cap -------------------------------------------------------- Market segment: STO Equities CCP/182 -------------------------------------------------------- Tick Size Table: MiFID II tick size table -------------------------------------------------------- MIC: XSTO -------------------------------------------------------- ICB Classification: Industry code: 30 Financials ------------------------------------------ Supersector code: 3020 Financial Services ------------------------------------------ For further information concerning this exchange notice please contact Listing Qualifications, telephone +46 8 405 72 80 or iss@nasdaq.com
Nasdaq Stockholm AB: Listing of Flerie AB on Nasdaq Stockholm
© 2024 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Nasdaq Stockholm welcomes Flerie to the Main Market | Stockholm, Jun 27, 2024 - Nasdaq (Nasdaq: NDAQ) announces that trading in the
shares of Flerie AB (ticker name: FLERIE) will commence today on the Nasdaq
Stockholm Main Market. Flerie is a Mid Cap company... ► Artikel lesen | |
| 26.06. | Nasdaq Stockholm AB: Last day of trading in Flerie AB | At the request of Flerie AB, the trading in the company's shares on Nasdaq
First North Growth Market is to cease. As from June 27, 2024, the shares will
be listed on Nasdaq Stockholm.
Last day of... ► Artikel lesen | |
| 26.06. | Nasdaq Stockholm AB: Listing of Flerie AB on Nasdaq Stockholm | Nasdaq Stockholm AB has assessed that Flerie AB, company registration number
559067-6820, fulfills Nasdaq Stockholm's listing requirements. Provided that
the prospectus is approved by the SFSA first... ► Artikel lesen | |
| 20.06. | Nasdaq Stockholm AB: The observation status for Flerie AB is removed | On May 14, 2024, the shares in Flerie AB, formerly named InDex Pharmaceuticals
Holding AB (the "Company") were given observation status with reference to
plans to carry out a reverse take-over.
On... ► Artikel lesen | |
| 12.06. | Nasdaq Stockholm AB: InDex Pharmaceuticals Holding AB changes name to Flerie AB | Commencing June 13, 2024, InDex Pharmaceuticals Holding AB shares will be
traded under its new name, Flerie AB.
New company name: Flerie AB
New short name: FLERIE
Unchanged ISIN code: SE0008966295
This... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
